尼古丁对下丘脑弧状核 POMC和NPY神经元的对立作用
E Ramírez-Sánchez1, A Mondragón-García1, J Garduño1
1Departamento de Fisiología, Facultad de Medicina, Universidad Nacional Autónoma de México (UNAM), Ciudad de México 04510, Mexico.
尼古丁刺激抑制食欲的普罗皮欧梅拉诺科丁 (POMC) 神经元,并抑制大脑中刺激食欲的神经Y (NPY) 神经元.
科学领域:
- 神经科学是一个神经科学.
- 内分泌学 在内分泌学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 垂体弧状核 (ARC) 通过不同的神经元群体调节能量稳态.
- 普罗皮欧梅拉诺科丁 (POMC) 神经元促进腹感,而神经Y (NPY) 神经元刺激食.
- 尼古丁对ARC神经元活动和食欲调节的影响尚未完全阐明.
研究的目的:
- 研究尼古丁对ARC中POMC和NPY神经元的直接影响.
- 确定参与尼古丁作用的特定尼古丁乙胆受体 (nAChR) 亚型.
- 阐明尼古丁诱导的食欲抑制背后的机制.
主要方法:
- 大脑切片中的ARC神经元的电生理记录.
- 在生理葡萄糖度下,尼古丁的应用.
- 对nAChR亚型的药理学操纵.
主要成果:
- 尼古丁增加了POMC神经元的发射速度.
- 尼古丁抑制了NPY神经元的发射速度.
- 尼古丁通过α7 nAChRs增强了POMC神经元的谷氨基基输入,通过α4β2 nAChRs增强了GABAergic输入到NPY神经元.
结论:
- 尼古丁通过差异调节POMC和NPY神经元活动.
- 特定的nAChR亚型调解尼古丁对这些ARC神经元的影响.
- 这些发现提供了对尼古丁厌食效应的机制性见解.
更多相关视频
12:19Live Imaging of Nicotine Induced Calcium Signaling and Neurotransmitter Release Along Ventral Hippocampal Axons
Published on: June 24, 2015
08:47Spectral Confocal Imaging of Fluorescently tagged Nicotinic Receptors in Knock-in Mice with Chronic Nicotine Administration
Published on: February 10, 2012
相关概念视频
Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating...
Regulation of Food Intake
Cholinergic Receptors: Nicotinic
There are two types of nicotinic receptors: neuromuscular (NM/NM/N1) and neuronal (NN/NN/N2). The two families differ based on their location and selectivity to...
Sympathetic Signaling
Sympathetic preganglionic fibers release the neurotransmitter acetylcholine (ACh) onto the ganglionic neurons in the...
Drugs Acting on Autonomic Ganglia: Blockers
Drugs Affecting Neurotransmitter Synthesis
